ArticleFrontiers in genetics2013

A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor.

Joanna M Lubieniecka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.